FIELD: medicine.
SUBSTANCE: can be used as method of treatment of osteomyelitis and septic arthritis, caused by bacterial agents, including with plural medicinal resistance. For this purpose mammal is introduced with pharmacologically effective amount of tigecycline separately or in combination with ryphampycine antibiotic. This agent is also offered also for manufacturing of medical products for treatment of given diseases.
EFFECT: invention provides increased efficiency of bone, marrow and joints infection treatment to preferential tigecycline distribution through bone tissue, marrow and synovial fluid.
48 cl, 5 dwg, 11 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL) PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL] UREA | 2012 |
|
RU2625305C2 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
| PYRIMIDINE GYRASE AND TOPOISOMERASE IV INHIBITORS | 2012 |
|
RU2609259C2 |
| COMPOUNDS AND METHODS OF TREATING INFECTIONS | 2014 |
|
RU2666540C2 |
| COMPOUNDS AND METHODS FOR TREATMENT OF INFECTIONS | 2018 |
|
RU2779024C2 |
| METHODS OF SCREENING TO IDENTIFY THERAPEUTIC CANDIDATES FOR THE TREATMENT OF INTRAOCULAR DISEASES OR DISORDERS | 2019 |
|
RU2795857C2 |
| PEPTIDES AND USE THEREOF | 2011 |
|
RU2590706C2 |
| COMPOSITION, CONTAINING HONEYSUCKLE EXTRACT, AND ANTIBIOTIC, PHARMACEUTICAL SET AND APPLICATION OF HONEYSUCKLE EXTRACT FOR OBTAINING MEDICATIONS | 2011 |
|
RU2571281C2 |
| STABILISED VANCOMYCIN FORMULATIONS | 2013 |
|
RU2675859C2 |
| METHOD FOR IDENTIFICATION OF NOSOCOMIAL OPPORTUNISTIC INFECTIONS PATHOGENS AND MARKERS OF THEIR RESISTANCE TO BETA-LACTAM ANTIBIOTICS AND GLYCOPEPTIDES IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR ANTIBACTERIAL THERAPY OPTIMISATION | 2016 |
|
RU2629322C1 |
